Autoantibodies in Diagnosis and
Follow-up of Rheumatic Diseases
Coordinators: Angela Tincani, MD, and Edward K.L.
Chan, PhD
Moderator: Pier Luigi Meroni, MD
Session
Objectives:
•
A review of new developments regarding autoantibodies in myositis,
including new autoantibodies in dermatomyositis
•
Construct a practical guide in using anti-neutrophil cytoplasmic antibody
versus anti-neutrophil autoantibodies
•
Identify rare antinuclear autoantibodies that rheumatologists should
know
•
Discuss the current ACR topic of ‘inaccurate results for antinuclear
antibody’ when using ANA Enzyme-linked
Immuno-Sorbent
Assay or coated beads for screening
Myositis autoantibodies-2008
update
by Ira N. Targoff, MD, University of Oklahoma Health
Sciences Center and Oklahoma Medical Research Foundation, Oklahoma City, OK
Anti-Neutrophil
Cytoplasmic Antibody and Perinuclear Anti-Neutrophil Cytoplasmic Antibody -
Clinical Relevance
by Allan Wiik, MD,
Statens Serum Institute, Denmark
pdf file 264kB
The Conundrum of Rare
but Clinically Important Autoantibodies
by Marvin J. Fritzler,
PhD., MD, University of Calgary, Canada
pdf file
508kB
Inaccurate
Results for ANA
by John A.
Goldman, MD, Atlanta, GA
Discussion Summary pdf file 11kB
